McMaster gets $5M to test prostate cancer vaccine

Hamilton researchers are attempting to create a prostate cancer vaccine that would use viruses to destroy cancer cells and trigger an immune response. Funded primarily by a $5-million grant from popular fundraiser Movember and Prostate Cancer Canada, the vaccine will be manufactured in Hamilton and Ottawa and tested on patients who currently have no other course of treatment. Read the article.

Scroll to Top